AnaptysBio, Inc.
ANAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$145 | -$164 | -$129 | -$58 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $34 | $33 | $27 | $15 |
| Change in WC | -$66 | -$0 | $7 | -$7 |
| Other Non-Cash | $40 | $8 | $19 | $2 |
| Operating Cash Flow | -$135 | -$121 | -$74 | -$46 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $394 | $0 |
| Inv. Purchases | -$380 | -$304 | -$803 | -$119 |
| Inv. Sales/Matur. | $476 | $449 | $408 | $159 |
| Other Inv. Act. | $0 | $0 | -$394 | $0 |
| Investing Cash Flow | $95 | $145 | -$395 | $39 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $35 | -$12 | $0 | $0 |
| Stock Issued | $101 | $2 | $12 | $3 |
| Stock Repurch. | -$0 | -$50 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8 | -$0 | $32 | $250 |
| Financing Cash Flow | $127 | -$59 | $44 | $252 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $87 | -$35 | -$424 | $245 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $36 | $71 | $496 | $251 |
| End Cash | $123 | $36 | $71 | $496 |
| Free Cash Flow | -$136 | -$122 | -$74 | -$47 |